Eosinophils infiltrated into the tumor after administration of the anti-CTLA-4 Ab, but depletion of eosinophils by anti-CD193 Ab treatment did not cancel the anti-tumor effect of the anti-CTLA-4 Ab (S3C Fig). This evidence concerns the gene CCR3 and neoplasm.